Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Leukemia 12Breast Neoplasms 9Neoplastic Cells, Circulating 7Prostatic Neoplasms 5Leukemia, Myeloid, Acute 5Multiple Myeloma 4Lung Neoplasms 4Head and Neck Neoplasms 4Colorectal Neoplasms 4Wilms Tumor 3Sarcoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasms, Plasma Cell 3Kidney Neoplasms 3Congenital Abnormalities 3Colonic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Intraductal, Noninfiltrating 3Unspecified Adult Solid Tumor, Protocol Specific 2Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 2Ovarian Neoplasms 2Esophageal Neoplasms 2Carcinoma, Ovarian Epithelial 2Breast Neoplasms, Male 2Adenocarcinoma Of Esophagus 2Waldenstrom Macroglobulinemia 1Uveal Melanoma 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1

Interventions

Cyclophosphamide 12Whole-Body Irradiation 10fludarabine phosphate 9Rituximab 9Peripheral Blood Stem Cell Transplantation 9Cyclosporine 9Mycophenolic Acid 7Filgrastim 7Etoposide 6Dexamethasone 6Busulfan 6Methotrexate 5Tacrolimus 4Carboplatin 4Bortezomib 4Vorinostat 3Thiotepa 3Radiotherapy 3Lenalidomide 3Irinotecan 3Cytarabine 3Calcium Dobesilate 3merphos 2liposomal amphotericin B 2laromustine 2ixabepilone 2entinostat 2Transplantation 2Therapeutics 2Prednisone 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Intraocular Lymphoma × Reverse Transcriptase Polymerase Chain Reaction × Clear all
NCT00720135 2015-06-08

Fusion Protein Cytokine Therapy After Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma

City of Hope Medical Center

Phase 1 Completed
9 enrolled
Lymphoid

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡